Assessment of Coronary Vasodilator Reserve by N-13 Ammonia PET Using the Microsphere Method and Patlak Plot Analysis

Overview

Journal Ann Nucl Med

Date 1995 Aug 1

PMID 8534582

Citations 1

Authors

E Tadamura

N Tamaki

Y Yonekura

T Kudoh

Y Magata

T Torizuka

M Tateno

R Nohara

S Sasayama

J Konishi

Affiliations

Soon will be listed here.

Abstract

Unlabelled: Noninvasive quantification of regional myocardial blood flow (MBF) has been successfully achieved with N-13 ammonia. The microsphere method as a simple method for quantifying regional myocardial blood flow was reevaluated in comparison with Patlak graphical analysis. In addition coronary vasodilator reserve (CVR) was estimated by both methods.

Methods: Dynamic N-13 ammonia PET studies were performed in 10 healthy volunteers and 10 patients with coronary artery disease at baseline and after dipyridamole infusion (0.56 mg/kg). MBF was estimated by the microsphere method at various times and by Patlak graphical analysis. In order to reduce the noise level in the microsphere method, MBF estimates were also performed after data in 10-40 seconds were averaged.

Results: In the studies on normal subjects MBF (ml/min/g) determined by the microsphere method significantly differs from time to time. However, MBF determined by the modified microsphere method [with average (Extraction fraction) x MBF values obtained between 100 and 120 sec] linearly correlated well with MBF by Patlak graphical analysis (r = 0.97, slope = 0.98, intercept = 0.20). In the studies on patients with coronary artery disease a good agreement of the MBF estimates was also observed (r = 0.97, slope = 0.98, intercept = 0.22). In the studies on the normal subjects and patients with coronary artery disease, CVR obtained by the modified microsphere method after correcting the overestimated MBF values also correlated well with that by Patlak graphical analysis (r = 0.90, slope = 1.14, intercept = -0.15, and r = 0.92, slope = 0.82, intercept = 0.25, respectively).

Conclusion: The modified microsphere method is a very simple and reliable approach for quantifying MBF with N-13 ammonia PET which is comparable to Patlak graphical analysis. It also makes possible CVR assessment as accurate as Patlak graphical analysis.

Citing Articles

Coronary vasomotor function assessed by positron emission tomography.

Tamaki N, Yoshinaga K, Naya M Eur J Nucl Med Mol Imaging. 2009; 37(6):1213-24.

PMID: 19937243 DOI: 10.1007/s00259-009-1311-x.

References

Krivokapich J, Stevenson L, Kobashigawa J, Huang S, Schelbert H . Quantification of absolute myocardial perfusion at rest and during exercise with positron emission tomography after human cardiac transplantation. J Am Coll Cardiol. 1991; 18(2):512-7. DOI: 10.1016/0735-1097(91)90608-c. View

Choi Y, Huang S, Hawkins R, Kuhle W, Dahlbom M, Hoh C . A simplified method for quantification of myocardial blood flow using nitrogen-13-ammonia and dynamic PET. J Nucl Med. 1993; 34(3):488-97. View

Nienaber C, Ratib O, Gambhir S, Krivokapich J, Huang S, Phelps M . A quantitative index of regional blood flow in canine myocardium derived noninvasively with N-13 ammonia and dynamic positron emission tomography. J Am Coll Cardiol. 1991; 17(1):260-9. DOI: 10.1016/0735-1097(91)90736-s. View

Hutchins G, Schwaiger M, Rosenspire K, Krivokapich J, Schelbert H, Kuhl D . Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol. 1990; 15(5):1032-42. DOI: 10.1016/0735-1097(90)90237-j. View

Weinberg I, Huang S, Hoffman E, Araujo L, Nienaber C, Grover-McKay M . Validation of PET-acquired input functions for cardiac studies. J Nucl Med. 1988; 29(2):241-7. View

Bellina C, Parodi O, Camici P, Salvadori P, Taddei L, Fusani L . Simultaneous in vitro and in vivo validation of nitrogen-13-ammonia for the assessment of regional myocardial blood flow. J Nucl Med. 1990; 31(8):1335-43. View

Shah A, Schelbert H, Schwaiger M, Henze E, Hansen H, Selin C . Measurement of regional myocardial blood flow with N-13 ammonia and positron-emission tomography in intact dogs. J Am Coll Cardiol. 1985; 5(1):92-100. DOI: 10.1016/s0735-1097(85)80089-9. View

Krivokapich J, Smith G, Huang S, Hoffman E, Ratib O, Phelps M . 13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation. 1989; 80(5):1328-37. DOI: 10.1161/01.cir.80.5.1328. View

Kuhle W, Porenta G, Huang S, Buxton D, Gambhir S, Hansen H . Quantification of regional myocardial blood flow using 13N-ammonia and reoriented dynamic positron emission tomographic imaging. Circulation. 1992; 86(3):1004-17. DOI: 10.1161/01.cir.86.3.1004. View

10.

Hara T, Michihata T, Yokoi F, Sakamoto S, Masuoka T, Iio M . Quantitative measurement of regional myocardial blood flow in patients with coronary artery disease by intravenous injection of 13N-ammonia in positron emission tomography. Eur J Nucl Med. 1990; 16(4-6):231-5. DOI: 10.1007/BF00842773. View

11.

Heymann M, Payne B, Hoffman J, Rudolph A . Blood flow measurements with radionuclide-labeled particles. Prog Cardiovasc Dis. 1977; 20(1):55-79. DOI: 10.1016/s0033-0620(77)80005-4. View

12.

Rosenspire K, Schwaiger M, Mangner T, Hutchins G, Sutorik A, Kuhl D . Metabolic fate of [13N]ammonia in human and canine blood. J Nucl Med. 1990; 31(2):163-7. View

13.

Tamaki N, Magata Y, Takahashi N, Kawamoto M, Torizuka T, Yonekura Y . Oxidative metabolism in the myocardium in normal subjects during dobutamine infusion. Eur J Nucl Med. 1993; 20(3):231-7. DOI: 10.1007/BF00170004. View

14.

Camici P, Chiriatti G, Lorenzoni R, Bellina R, Gistri R, Italiani G . Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol. 1991; 17(4):879-86. DOI: 10.1016/0735-1097(91)90869-b. View

15.

Schelbert H, Phelps M, Huang S, MACDONALD N, Hansen H, Selin C . N-13 ammonia as an indicator of myocardial blood flow. Circulation. 1981; 63(6):1259-72. DOI: 10.1161/01.cir.63.6.1259. View

16.

Araujo L, Lammertsma A, Rhodes C, McFalls E, Iida H, Rechavia E . Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography. Circulation. 1991; 83(3):875-85. DOI: 10.1161/01.cir.83.3.875. View

17.

Bergmann S, Herrero P, Markham J, Weinheimer C, WALSH M . Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol. 1989; 14(3):639-52. DOI: 10.1016/0735-1097(89)90105-8. View

18.

Klocke F . Coronary blood flow in man. Prog Cardiovasc Dis. 1976; 19(2):117-66. DOI: 10.1016/0033-0620(76)90020-7. View

19.

Iida H, Kanno I, Takahashi A, Miura S, Murakami M, Takahashi K . Measurement of absolute myocardial blood flow with H215O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effect. Circulation. 1988; 78(1):104-15. DOI: 10.1161/01.cir.78.1.104. View

20.

Gambhir S, Schwaiger M, Huang S, Krivokapich J, Schelbert H, Nienaber C . Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med. 1989; 30(3):359-66. View